The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 22, 2020

Filed:

Jul. 20, 2015
Applicant:

Allergan, Inc., Irvine, CA (US);

Inventors:

Anuradha V. Gore, Aliso Viejo, CA (US);

Hao Hou, Irvine, CA (US);

Chetan P. Pujara, Irvine, CA (US);

Sesha Neervannan, Irvine, CA (US);

Ke Wu, Irvine, CA (US);

Assignee:

ALLERGAN, INC., Irvine, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2019.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 47/10 (2017.01); A61K 38/13 (2006.01); A61K 47/36 (2006.01); A61K 47/02 (2006.01); A61K 47/26 (2006.01); A61K 47/38 (2006.01); B65D 81/32 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0051 (2013.01); A61K 9/0048 (2013.01); A61K 9/10 (2013.01); A61K 38/13 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); B65D 81/32 (2013.01);
Abstract

The present disclosure relates to suspension formulations and systems for the treatment of ocular conditions. The suspension formulations can include cyclosporin A and in some embodiments, Form 1 or Form 2 cyclosporin A. A delivery system can be provided that includes two parts, a first part containing particles of cyclosporin and a second part containing other components that can be combined with the first part to make a suspension formulation. The suspension can be injected into the subconjunctival or other periocular space to treat ocular conditions, such as dry eye disease.


Find Patent Forward Citations

Loading…